Tympanogen
Richmond
About Tympanogen
Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Last round: Series Unknown (Mar 2025)
- Website: tympanogen.com
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/tympanogen-76497 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.